Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-028793
Filing Date
2024-02-28
Accepted
2024-02-28 17:16:51
Documents
6
Effectiveness Date
2024-02-28

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm247345d1_s8.htm S-8 66951
2 EXHIBIT 5.1 tm247345d1_ex5-1.htm EX-5.1 10995
3 EXHIBIT 23.2 tm247345d1_ex23-2.htm EX-23.2 2272
4 EX-FILING FEES tm247345d1_ex-filingfees.htm EX-FILING FEES 28181
5 GRAPHIC tm247345d1img001.jpg GRAPHIC 2224
6 GRAPHIC tm247345d1img002.jpg GRAPHIC 9909
  Complete submission text file 0001104659-24-028793.txt   126448
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277474 | Film No.: 24696935
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)